Skip to main content

Table 1 Participant characteristics of the two patient cohorts

From: Patient Endorsement of the Outcome Measures in Rheumatology (OMERACT) Total Joint Replacement (TJR) clinical trial draft core domain set

 

OMERACT Patient research partner (PRP) Cohort survey (N = 47)

Total Joint Replacement SVPH Cohort (N = 147)

# Survey participants

N = 31 (66%)

N = 118a (80%)

% Maleb

4 (13%)

50 (47%)

Age categoryb

 18-24

0

0

 25-34

1 (3%)

0

 35-44

3 (10%)

1 (1%)

 45-54

9 (30%)

5 (5%)

 55-64

11 (37%)

26 (25%)

 65-74

6 (20%)

36 (34%)

 ≥75

0

37 (35%)

 Missing

2 (7%)

2

 Had a joint replacement

13 (42%)

107 (100%)

Type of arthritis

 Osteoarthritis

2 (7%)

93 (87%)

 Rheumatoid arthritis

15 (54%)

4 (4%)

 Other inflammatory arthritis

7 (26%)

7 (6%)

 Joint aches/pains, no arthritis diagnosed or no joint aches/pains

4 (15%)

3 (3%)

  1. aOf the 147 patients who received the survey (email, n = 124; mailed survey, n = 23), 118 responded (email, n = 109; mailed survey, n = 9), of which 107 were usable (email, n = 99; mailed survey, n = 9). Therefore, most proportions are out of 107 (73% valid surveys)
  2. bMissing responses for variables for OMERACT PRPs vs. TJR SVPH cohorts: sex: 0 vs. 2; age, 0 vs. 2